By contrast, transcript expression levels of kinase-deficient TrkB.T1 were significantly increased in both CIMP and non-CIMP gliomas (LGG and GBM) compared with all normal brain regions (Fig. 2a, Table 2). This evidence concerns the gene NTRK2 and central nervous system cancer.